NMTC

0.65213.38%
JS

Jeffrey S. Mathiesen

Vice Chair & Lead Independent Director

Mr. Jeffrey S. Mathiesen, also known as Jeff, CPA, served as Chief Financial Officer and Treasurer at Solana Company (formerly known as Helius Medical Technologies, Inc.) since June 14, 2021 until May 12, 2026 and served as its Secretary since June 14, 2021 until May 12, 2026 and was its Director since May 23, 2022 until October 30, 2025. He served as an Independent Director of Healthcare Triangle, Inc. since March 31, 2022 until December 23, 2022. He served as an Independent Director of Solana Company (formerly known as Helius Medical Technologies, Inc.) since June 9, 2020 until June 14, 2021. Mr. Mathiesen served as the Chief Financial Officer of Gemphire Therapeutics Inc. from September 2015 to September 18, 2018 and served as its Secretary until September 18, 2018. Mr. Mathiesen has been Vice Chair and Lead Independent Director since March 2020 and as Director since September 2015 of Panbela Therapeutics, Inc. He served as a Director of eNeura Inc from July 2018 to February 2020. He served as Consultant at Gemphire Therapeutics Inc. since September 18, 2018 until May 18, 2019. Mr. Mathiesen was a Consultant of Gemphire Therapeutics Inc. from August 2015 to September 2015. Mr. Mathiesen served as the Chief Financial Officer and Company Secretary at CHF Solutions, Inc (Alternate name: Sunshine Heart Inc.) from March 2011 to January 2015 and from July 2011 to January 2015, respectively and served as its Principal Accounting Officer until January 2015. He has senior-level financial management experience with technology-based corporations. Prior to Sunshine Heart, he served as the Chief Financial Officer and Vice President of Zareba Systems, Inc. from December 9, 2005 to April 2010 and served as its Principal Accounting Officer. He served as the Chief Financial Officer and Vice President of Delphax Technologies Inc. from July 2004 to December 9, 2005 and served as its Principal Accounting Officer. Mr. Mathiesen Headed The Mathiesen Group Inc. from April 2003 to July 2004. From September 1996 to 2003, he served as Vice President and Chief Financial Officer and then Vice President of Business Development at Micro Component Technology Inc. St. Paul, Minn. supplier of automation equipment and software for the semiconductor industry. He served as a Vice President and Chief Financial Officer of Recovery Engineering Inc. from 1991 to 1996. He worked for Teewinot Life Sciences Corporation from March 2019 to December 2019, where he served as Chief Financial Officer from March 2019 to October 2019 and later Advisor to the Chief Executive Officer from October 2019 to December 2019 and in August 2020, Teewinot Life Sciences filed a voluntary petition under Chapter 11 of the United States Bankruptcy Code. Mr. Mathiesen began his career at Deloitte & Touche LLP in 1983. He has been an Additional Director at Cimarron Medical, Inc. since September 24, 2015. He has been Independent Director of NeuroOne Medical Technologies Corporation since August 2017 and served as a Director of NeuroOne, Inc. from April 2017 to December 2019. He is a Certified Public Accountant. He is a summa cum laude graduate of the University of South Dakota, with a Bachelor of Science degree in Accounting.

Positions